ArticleClinical cancer research : an official journal of the American Association for Cancer Research2013

A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia.

Mao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.